T1	PROC 47 75	Estudio de extensión abierto
T2	PROC 107 153	evaluar la seguridad, tolerabilidad y eficacia
T3	Date 154 167	a largo plazo
#1	AnnotatorNotes T3	C1517942 Long-term Follow-up
T4	Route 189 191	SC
T5	LIVB 195 216	participantes adultos
T6	Age 209 216	adultos
T7	DISO 221 241	penfigoide ampolloso
#2	AnnotatorNotes T7	C0030805; Bullous pemphigoid; Disease or Syndrome
T8	PROC 259 276	Estudio de fase 3
T9	PROC 282 328	evaluar la seguridad, tolerabilidad y eficacia
T10	Route 350 352	SC
T11	LIVB 356 377	participantes adultos
T12	Age 370 377	adultos
T13	DISO 382 402	penfigoide ampolloso
#3	AnnotatorNotes T13	C0030805; Bullous pemphigoid; Disease or Syndrome
T14	DISO 424 445	Enfermedad autoinmune
#4	AnnotatorNotes T14	C0004364; Autoimmune Diseases; Disease or Syndrome
T15	DISO 458 475	ampollas cutáneas
#5	AnnotatorNotes T15	C0005758; Bulla; Finding
T16	DISO 478 485	prurito
#6	AnnotatorNotes T16	C0033774; Pruritus; Sign or Symptom
T17	DISO 510 530	Penfigoide ampolloso
#7	AnnotatorNotes T17	C0030805; Bullous pemphigoid; Disease or Syndrome
T18	PROC 729 738	protocolo
#8	AnnotatorNotes T18	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T19	PROC 767 790	métodos anticonceptivos
#9	AnnotatorNotes T19	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T20	LIVB 846 867	Varones participantes
T21	PROC 872 893	método anticonceptivo
#10	AnnotatorNotes T21	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T22	DEVI 910 916	condón
#11	AnnotatorNotes T22	C0009653; Condoms, Male; Medical Device | C0677582; Condoms, Unspecified; Medical Device
T23	LIVB 928 952	participantes masculinos
T24	Neg_cue 953 955	no
T25	PROC 956 969	esterilizados
#12	AnnotatorNotes T25	C0038280; Sterilization for infection control; Health Care Activity | C0038288; Sexual sterilization; Therapeutic or Preventive Procedure
T26	Negated 956 969	esterilizados
T27	PROC 1016 1040	Consentimiento Informado
#13	AnnotatorNotes T27	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T28	CHEM 1079 1082	PEI
T29	Neg_cue 1154 1162	negativo
T30	CHEM 1254 1257	PEI
T31	PROC 1324 1347	métodos anticonceptivos
#14	AnnotatorNotes T31	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T32	PROC 1364 1373	protocolo
#15	AnnotatorNotes T32	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T33	PROC 1393 1417	Consentimiento Informado
#16	AnnotatorNotes T33	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T34	CHEM 1444 1447	PEI
T35	DISO 1479 1489	Enfermedad
#17	AnnotatorNotes T35	C0012634; Disease; Disease or Syndrome | C0221423; Illness (finding); Sign or Symptom
T36	PROC 1630 1653	intervención quirúrgica
#18	AnnotatorNotes T36	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T37	LIVB 1725 1737	investigador
#19	AnnotatorNotes T37	C0035173; Research Personnel; Professional or Occupational Group
T38	Spec_cue 1739 1744	pueda
T39	Speculated 1745 1754	confundir
T40	Spec_cue 1795 1801	riesgo
T41	LIVB 1819 1831	participante
T42	DISO 1837 1854	Hipersensibilidad
#20	AnnotatorNotes T42	C0020517; Hypersensitivity; Pathologic Function | C0429891; Hypersensitivity finding; Finding | C0585186; Cutaneous hypersensitivity; Disease or Syndrome
T43	CHEM 1867 1870	PEI
T44	CHEM 1889 1900	excipientes
#21	AnnotatorNotes T44	C0015237; Pharmaceutical Excipient; Biomedical or Dental Material
T45	PROC 1690 1704	proceso médico
T46	Negated 1180 1188	embarazo
T47	Speculated 1819 1831	participante
T48	PROC 579 585	visita
#22	AnnotatorNotes T48	C1512346; Patient Visit; Health Care Activity
T49	Date 589 601	la semana 36
T50	CHEM 332 349	efgartigimod PH20
T51	CHEM 171 188	efgartigimod PH20
T52	PROC 1534 1556	cirugía mayor reciente
#23	AnnotatorNotes T52	recent surgery C2169607
T53	PROC 1518 1530	intervención
T54	LIVB 1263 1297	mujeres con capacidad reproductiva
#24	AnnotatorNotes T54	Female of child bearing age C1960468
T55	LIVB 1092 1126	mujeres con capacidad reproductiva
#25	AnnotatorNotes T55	Female of child bearing age C1960468 
T56	PROC 659 691	consentimiento informado firmado
T57	Duration 1561 1572	los 3 meses
T58	Spec_cue 1601 1610	intención
T59	Speculated 1630 1653	intervención quirúrgica
T60	Speculated 1690 1704	proceso médico
T61	PROC 1170 1188	prueba de embarazo
T62	ANAT 1192 1197	orina
T63	CONC 560 572	Finalización
T64	Observation 633 642	Capacidad
T65	Observation 694 724	cumplimiento de los requisitos
T66	CONC 1062 1074	última dosis
T67	Result_or_Value 1144 1162	resultado negativo
T68	CONC 1214 1227	momento basal
T69	CONC 1427 1439	última dosis
T70	Quantifier_or_Qualifier 1490 1516	clínicamente significativa
T71	CONC 1584 1597	momento basal
T72	Observation 1690 1704	proceso médico
T73	Observation 1745 1769	confundir los resultados
T74	Observation 1795 1801	riesgo
T75	Quantifier_or_Qualifier 1802 1810	excesivo
T76	Patient 195 216	participantes adultos
T77	Patient 356 377	participantes adultos
T78	Patient 846 867	Varones participantes
T79	Patient 928 952	participantes masculinos
T80	Patient 1092 1099	mujeres
T81	Patient 1263 1270	mujeres
T82	History_of 1518 1547	intervención de cirugía mayor
T83	Future 1630 1653	intervención quirúrgica
T84	Other 1725 1737	investigador
T85	Patient 1819 1831	participante
T86	History_of 1837 1854	Hipersensibilidad
